1 recruiting, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
Follow Vemurafenib plus Cobimetinib: new trials by email Literature Review of Vemurafenib plus Cobimetinib trials Research Report on Vemurafenib plus Cobimetinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) Olaparib, Dasatinib, Nivolumab plus Ipilimumab - Lymphoma, Non-Hodgkin, Multiple Myeloma | Phase 2 | Recruiting | Canadian Cancer Trials Group | 720 | 2018-03-23 | 2026-03-27 |
| Vemurafenib Plus Cobimetinib in Metastatic Melanoma Vemurafenib plus cobimetinib, Positron Emission Tomography, Tissue sampling - Metastatic Melanoma | Phase 2 | Terminated | Netherlands Working Group on Immunotherapy of Oncology | 78 | 2014-12-01 | 2022-11-30 |
Lymphoma, Non-Hodgkin (1) · Melanoma (1) · Multiple Myeloma (1)
Canadian Cancer Trials Group (1) · Netherlands Working Group on Immunotherapy of Oncology (1)
Canada (1) · Netherlands (1)
Daniel J Renouf (1) · Lillian Siu (1)